Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Pan Afr Med J ; 34: 182, 2019.
Article in English | MEDLINE | ID: mdl-32153722

ABSTRACT

INTRODUCTION: children pay a heavy price for infection with the hepatitis B virus (HBV). The objective of this work was to determine the prevalence of hepatitis B and describe the associated factors in children at the pediatric department of Donka Hospital. METHODS: this was a cross-sectional study of a cohort of children in the pediatric department of Donka Hospital. HBsAg was performed by using an immunochromatographic method. The analysis of the data was done with software R. The proportions were compared using the Chi-square test or the Fisher test at the significance level of 5%. A logistic regression model was used to explain the prevalence of hepatitis B. RESULTS: one hundred and forty-nine children were recruited between February and July 2017. HBsAg was present in 12 children, i.e. 8.16% (95% CI: 4.29-13.82). The average age was 93.32 months (IQR: 6-180). Male children were the most affected (n = 11, P <0.05), with a sex ratio of 1.01. The majority (51.35%) were on AZT + 3TC + NVP pediatric form and 25% were on AZT + 3TC + NVP adult form and 23.65% on TDF + FTC + EFV. In univariate analysis, ALT, HBsAg positivity, and maternal HBV vaccination status were associated with the prevalence of HBsAg (P <0.05). CONCLUSION: the prevalence of co-infection in children and adults is almost identical in our context. Hence the importance of strengthening preventive measures at all levels, especially the vaccination of children and mothers.


Subject(s)
Anti-HIV Agents/administration & dosage , HIV Infections/epidemiology , Hepatitis B Surface Antigens/blood , Hepatitis B/epidemiology , Adolescent , Child , Child, Preschool , Cohort Studies , Cross-Sectional Studies , Drug Therapy, Combination , Female , Guinea/epidemiology , HIV Infections/drug therapy , Hepatitis B/drug therapy , Hepatitis B Vaccines/administration & dosage , Humans , Infant , Infant, Newborn , Male , Prevalence
2.
BMC Dermatol ; 15: 18, 2015 Dec 15.
Article in English | MEDLINE | ID: mdl-26666633

ABSTRACT

BACKGROUND: Abscess formation is a frequent local complication of leg erysipelas. In this study we aimed at identifying factors associated with abscess formation of leg erysipelas in patients in sub-Saharan African countries. METHOD: This is a multicenter prospective study conducted in dermatology units in eight sub-Saharan African countries from October 2013 to September 2014. We performed univariate and multivariate analysis to compare characteristics among the group of patients with leg erysipelas complicated with abscess against those without this complication. RESULTS: In this study, 562 cases of leg erysipelas were recruited in the eight sub-Saharan African countries. The mean age of patients was 43.67 years (SD =16.8) (Range: 15 to 88 years) with a sex-ratio (M/F) of 5/1. Out of the 562 cases, 63 patients (11.2%) had abscess formation as a complication. In multivariate analysis showed that the main associated factors with this complication were: nicotine addiction (aOR = 3.7; 95 % CI = [1.3 - 10.7]) and delayed antibiotic treatment initiation (delay of 10 days or more) (aOR = 4.6; 95 % CI = [1.8 - 11.8]). CONCLUSION: Delayed antibiotics treatment and nicotine addiction are the main risk factors associated with abscess formation of leg erysipelas in these countries. However, chronic alcohol intake, which is currently found in Europe as a potential risk factor, was less frequent in our study.


Subject(s)
Abscess/epidemiology , Erysipelas/complications , Erysipelas/drug therapy , Leg Dermatoses/epidemiology , Tobacco Use Disorder/epidemiology , Abscess/microbiology , Adolescent , Adult , Africa South of the Sahara/epidemiology , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Female , Humans , Leg , Leg Dermatoses/microbiology , Male , Middle Aged , Prospective Studies , Risk Factors , Time-to-Treatment , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL